|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 15/10 | |
| C12N 5/078 | |||
| C12N 9/22 | |||
| C12N 15/11 | |||
| C12N 15/86 |
| (11) | Patento numeris | 3294873 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16793259.9 |
| Europos patento paraiškos padavimo data | 2016-05-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-03-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/031224 |
| Data | 2016-05-06 |
| (87) | Numeris | WO 2016/182917 |
| Data | 2016-11-17 |
| (30) | Numeris | Data | Šalis |
| 201562158882 P | 2015-05-08 | US |
| (72) |
BAUER, Daniel E., US
ORKIN, Stuart H., US
SANJANA, Neville, US
SHALEM, Ophir, US
ZHANG, Feng, US
|
| (73) |
The Broad Institute, Inc.,
415 Main Street, Cambridge, MA 02142,
US
Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02142, US The Children`s Medical Center Corporation, 55 Shattuck Street, Boston, Massachusetts 02115, US |
| (54) | TARGETING BCL11A ENHANCER FUNCTIONAL REGIONS FOR FETAL HEMOGLOBIN REINDUCTION |
| TARGETING BCL11A ENHANCER FUNCTIONAL REGIONS FOR FETAL HEMOGLOBIN REINDUCTION |